CD44 and breast carcinoma: Later, aldehyde dehydrogenase (ALDH) 1 expression and/or its activity were identified to be a marker for breast cancer stem/progenitor cells; fewer ALDH1 positive tumor cells than CD44+/CD24−/low tumor cells were required to generate tumors in vivo[5].